Identifying Improvements in an ED Elder Friendly Area Based on Patient Experience (EDEFA_TheirVoice Project)
NCT ID: NCT03717324
Last Updated: 2018-10-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2018-10-20
2019-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The project will use a creative problem-solving methodology (Design Thinking) to analyze the care process based on the experience of Elder Friendly Area (EFA) users and their families
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comprehensive Geriatric Assessment in an Emergency Department
NCT03786250
Enhancing the Emergency Department Experience for Older Adults: Study Protocol for the Implementation of a Comfort Menu and Cart
NCT06681376
E-health Enhanced Motor-cognitive Training for AED Discharged Older Adults With Cognitive Frailty
NCT05750121
Outreach-ER: A Dementia Care Intervention Program
NCT05451693
Evaluation of an Innovative Information, Training and Social Support Intervention "INFOSADEM" to Principal Caregivers of Dementia Patients Living at Home
NCT04036955
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients: Patients/caregivers attended in the Emergency Department's EFA will participate . In the first fieldwork, 50-60 patients will participate, conducting a self-completed interview (prior informed consent, 10 minutes long).
In the qualitative research phase, 5-10 patients/caregivers conduct a 30-minute interview with the Design Thinking professional. The co-creation workshop lasts a couple of hours and 5 to 10 patients/caregivers will participate. In the second fieldwork another 50-60 patients will participate. In total, between 110 and 140 patients will be enrolled.
Ethics: Patients/caregivers will be provided with a patient information sheet and informed consent prior to participation. Patient experience data will be collected by Design Thinking professional on an anonymous basis and will always be handled on an aggregate basis.
Funding: The project will be developed in collaboration with Merck Sharp \& Dohme Spain, with which there is an agreement signed (Fundació de Gestió HSCSP - MSD). For the correct development of it, MSD has hired a company expert in the development of this type of dynamics (Thinkers\&Co) which will participate actively in all meetings and workshops and will be responsible for collecting the opinion of the patient anonymously and manage this information in an aggregate way, always with the intention of identifying the points of improvement on which later health professionals will work with the methodology described. However, no monetary payment will be made to the hospital, to the emergency department or to the professionals involved. The collaboration of MSD and Thinkers\&Co will not affect the independent nature of the project.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
First evaluation group (survey_1)
Patients/caregivers attended in the Emergency Department Elder Friendly Area (EFA)
No interventions assigned to this group
Co-creation group
Patients/caregivers attended in the Emergency Department Elder Friendly Area (EFA) who want to participate in the co-creation workshop
Procedure created in co-creation group
Interventions will be those obtained from the co-creation workshop with patients
Second evaluation group (survey_2)
Patients/caregivers attended in the Emergency Department Elder Friendly Area (EFA), after improvements are made
Procedure created in co-creation group
Interventions will be those obtained from the co-creation workshop with patients
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Procedure created in co-creation group
Interventions will be those obtained from the co-creation workshop with patients
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
65 Years
110 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Merck Sharp & Dohme LLC
INDUSTRY
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mireia Puig
Role: PRINCIPAL_INVESTIGATOR
Hospital de la Santa Creu i Sant Pau, Emergency Department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital de la Santa Creu i Sant Pau
Barcelona, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Mireia Puig
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IIBSP-EXP-2018-80
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.